Patients presenting to the hospital with MRSA pneumonia: Differentiating characteristics and outcomes with empiric treatment

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Minejima, Emi ^a   Lou, Mimi ^a   Nieberg, Paul ^b   Wong Beringer, Annie ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Community onset pneumonia; Healthcare associated pneumonia; Methicillin resistant Staphylococcus aureus; Pneumonia; Risk factors

Indexed keywords

LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

AGED; ARTICLE; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE; INTERMEDIATE RISK PATIENT; LENGTH OF STAY; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; PNEUMONIA SEVERITY INDEX; PRESCRIPTION; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SHORR SCORING SYSTEM; TREATMENT FAILURE; TREATMENT RESPONSE; COMPARATIVE STUDY; EPIDEMIOLOGY; HOSPITAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CALIFORNIA; FEMALE; HOSPITALS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84900421957     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-252     Document Type: Article

References (13)

1. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010, 23(3):616-687. 10.1128/CMR.00081-09, 2901661, 20610826.
2. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007, 13(12):1840-1846. 10.3201/eid1312.070629, 2876761, 18258033.
3. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010, 51(Suppl 1):S81-S87.
4. Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest 2006, 130(4):947-955. 10.1378/chest.130.4.947, 17035423.
5. Wunderink RG. How important is methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia and what is best antimicrobial therapy?. Infect Dis Clin North Am 2013, 27(1):177-188. 10.1016/j.idc.2012.11.006, 23398873.
6. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010, 10(4):279-287. 10.1016/S1473-3099(10)70032-3, 20334851.
7. Murphy CR, Quan V, Kim D, Peterson E, Whealon M, Tan G, Evans K, Meyers H, Cheung M, Lee BY, Mukamel DB, Huang SS. Nursing home characteristics associated with methicillin-resistant Staphylococcus aureus (MRSA) Burden and Transmission. BMC Infect Dis 2012, 12:269. 10.1186/1471-2334-12-269, 3528666, 23095678.
8. Shorr AF, Myers DE, Huang DB, Nathanson BH, Emons MF, Kollef MH. A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis 2013, 13(1):268. 10.1186/1471-2334-13-268, 3681572, 23742753.
9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36(5):309-332. 10.1016/j.ajic.2008.03.002, 18538699.
10. Society AT, . America IDSo Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171(4):388-416. America IDSo.
11. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS, Singer DE. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA 1998, 279(18):1452-1457. 10.1001/jama.279.18.1452, 9600479.
12. Jung WJ, Kang YA, Park MS, Park SC, Leem AY, Kim EY, Chung KS, Kim YS, Kim SK, Chang J, Jung JY. Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia. BMC Infect Dis 2013, 13:370. 10.1186/1471-2334-13-370, 3751064, 23937553.
13. Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA, . Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011, 11(3):181-189. 10.1016/S1473-3099(10)70314-5, 21256086, Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.